Swiss National Bank
LLY icon

Swiss National Bank’s Eli Lilly LLY Stock Holding History

Swiss National Bank’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17B Buy
2,358,310
+153,800
+7% +$156M 1.25% 10
2025
Q4 		$2.37B Sell
2,204,510
-117,680
-5% -$113M 1.41% 10
2025
Q3 		$1.77B Sell
2,322,190
-117,000
-5% -$87.1M 1.03% 11
2025
Q2 		$1.9B Buy
2,439,190
+163,400
+7% +$127M 1.14% 11
2025
Q1 		$1.88B Sell
2,275,790
-6,400
-0.3% -$5.33M 1.33% 11
2024
Q4 		$1.76B Sell
2,282,190
-115,700
-5% -$95.8M 1.17% 10
2024
Q3 		$2.12B Buy
2,397,890
+5,100
+0.2% +$4.59M 1.38% 10
2024
Q2 		$2.17B Sell
2,392,790
-23,700
-1% -$19M 1.49% 8
2024
Q1 		$1.88B Sell
2,416,490
-106,800
-4% -$76M 1.32% 8
2023
Q4 		$1.47B Sell
2,523,290
-72,000
-3% -$42M 1.08% 11
2023
Q3 		$1.39B Sell
2,595,290
-322,000
-11% -$166M 1.09% 12
2023
Q2 		$1.37B Sell
2,917,290
-288,000
-9% -$121M 0.93% 14
2023
Q1 		$1.1B Sell
3,205,290
-77,200
-2% -$26M 0.75% 18
2022
Q4 		$1.2B Sell
3,282,490
-217,558
-6% -$77.1M 0.86% 16
2022
Q3 		$1.13B Sell
3,500,048
-11,400
-0.3% -$3.61M 0.81% 16
2022
Q2 		$1.14B Sell
3,511,448
-10,300
-0.3% -$3.09M 0.77% 19
2022
Q1 		$1.01B Buy
3,521,748
+431,200
+14% +$111M 0.57% 24
2021
Q4 		$854M Sell
3,090,548
-132,600
-4% -$33.6M 0.51% 32
2021
Q3 		$745M Sell
3,223,148
-98,800
-3% -$24.4M 0.47% 39
2021
Q2 		$762M Sell
3,321,948
-543,650
-14% -$109M 0.47% 37
2021
Q1 		$722M Buy
3,865,598
+66,100
+2% +$12.9M 0.48% 38
2020
Q4 		$642M Sell
3,799,498
-90,000
-2% -$13.4M 0.46% 43
2020
Q3 		$576M Sell
3,889,498
-51,400
-1% -$7.96M 0.45% 43
2020
Q2 		$647M Buy
3,940,898
+21,000
+0.5% +$3.22M 0.55% 34
2020
Q1 		$544M Buy
3,919,898
+681,300
+21% +$93.6M 0.58% 32
2019
Q4 		$426M Sell
3,238,598
-137,400
-4% -$15.9M 0.44% 40
2019
Q3 		$378M Sell
3,375,998
-55,558
-2% -$6.19M 0.4% 48
2019
Q2 		$380M Sell
3,431,556
-77,700
-2% -$9.15M 0.41% 45
2019
Q1 		$455M Sell
3,509,256
-184,087
-5% -$22.4M 0.5% 35
2018
Q4 		$427M Buy
3,693,343
+1,600
+0% +$179K 0.55% 32
2018
Q3 		$396M Sell
3,691,743
-159,400
-4% -$15.9M 0.44% 44
2018
Q2 		$329M Buy
3,851,143
+84,800
+2% +$6.97M 0.38% 50
2018
Q1 		$291M Sell
3,766,343
-407,400
-10% -$32.8M 0.36% 55
2017
Q4 		$353M Buy
4,173,743
+16,300
+0.4% +$1.39M 0.38% 50
2017
Q3 		$356M Buy
4,157,443
+36,000
+0.9% +$2.95M 0.41% 47
2017
Q2 		$339M Buy
4,121,443
+110,000
+3% +$8.97M 0.4% 45
2017
Q1 		$337M Buy
4,011,443
+781,800
+24% +$62.6M 0.42% 39
2016
Q4 		$238M Buy
3,229,643
+25,300
+0.8% +$1.88M 0.37% 50
2016
Q3 		$257M Sell
3,204,343
-45,500
-1% -$3.64M 0.41% 44
2016
Q2 		$256M Buy
3,249,843
+196,000
+6% +$14.8M 0.41% 43
2016
Q1 		$211M Buy
3,053,843
+765,400
+33% +$57.9M 0.39% 46
2015
Q4 		$193M Buy
2,288,443
+26,100
+1% +$2.17M 0.47% 38
2015
Q3 		$189M Buy
2,262,343
+172,100
+8% +$14.5M 0.49% 36
2015
Q2 		$175M Buy
2,090,243
+59,600
+3% +$4.54M 0.45% 40
2015
Q1 		$148M Buy
2,030,643
+541,400
+36% +$38.5M 0.39% 50
2014
Q4 		$103M Sell
1,489,243
-240,000
-14% -$16.2M 0.38% 56
2014
Q3 		$112M Sell
1,729,243
-29,200
-2% -$1.85M 0.43% 46
2014
Q2 		$109M Sell
1,758,443
-200,500
-10% -$12M 0.4% 52
2014
Q1 		$115M Sell
1,958,943
-65,600
-3% -$3.66M 0.45% 37
2013
Q4 		$103M Sell
2,024,543
-273,600
-12% -$13.7M 0.4% 52
2013
Q3 		$116M Buy
2,298,143
+30,500
+1% +$1.6M 0.48% 37
2013
Q2 		$111M Buy
+2,267,643
New +$123M 0.49% 36

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Swiss National Bank's LLY Position: Q1 2026 in Review

Swiss National Bank increased its Eli Lilly (LLY) stake by 7% in Q1 2026, buying an estimated $156M and bringing the position to 2,358,310 shares worth $2.17B. The position accounts for 1.25% of the portfolio, ranked #10.

Swiss National Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.37B in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Swiss National Bank held 2,358,310 shares of Eli Lilly worth $2.17B as of Q1 2026.
  • Swiss National Bank bought 153,800 Eli Lilly shares in Q1 2026, an estimated $156M.
  • Eli Lilly made up 1.25% of Swiss National Bank's portfolio in Q1 2026, its #10 holding.
  • Swiss National Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Swiss National Bank's Eli Lilly position peaked at $2.37B in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.